Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status (Q46846171)

25 December 2017

title

Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status (English)

1 reference

25 December 2017

1 reference

5

1 reference

25 December 2017

Jolanta Bernatoniene

2

object named as

Jolanta Bernatoniene

1 reference

25 December 2017

Andrew J. Pollard

4

object named as

Andrew J Pollard

1 reference

25 December 2017

author name string

Qibo Zhang

1

1 reference

25 December 2017

Linda Bagrade

3

1 reference

25 December 2017

James C Paton

6

1 reference

25 December 2017

Adam Finn

7

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

25 December 2017

European Journal of Immunology

published in

1 reference

25 December 2017

volume

36

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

46-57

1 reference

25 December 2017

Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

A conserved tryptophan in pneumolysin is a determinant of the characteristics of channels formed by pneumolysin in cells and planar lipid bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

Mechanism and function of a newly identified CpG DNA motif in human primary B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

Pneumococcal disease: prospects for a new generation of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Novel pneumococcal surface proteins: role in virulence and vaccine potential

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Human antibodies to pneumococcal surface protein A in health and disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Nasopharyngeal colonization during the first year of life

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

The epidemiology of pneumococcal infection in children in the developing world

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

The immune response to pneumococcal proteins during experimental human carriage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Anti-PsaA and the risk of pneumococcal AOM and carriage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

The immune response in adenoids and tonsils

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Spread of Streptococcus pneumoniae in Families. I. Carriage Rates and Distribution of Types

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Pneumococcal surface adhesin A antibody concentration in serum and nasopharyngeal carriage of Streptococcus pneumoniae in young African infants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Immunoglobulin-secreting Cells in the Surface Secretion on the Pharyngeal Tonsils

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Antibody production directed against pneumococci by immunocytes in the adenoid surface secretion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Severity of infections in IgA deficiency: correlation with decreased serum antibodies to pneumococcal polysaccharides and decreased serum IgG2 and/or IgG4.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

IgG subclass response and opsonization of Streptococcus pneumoniae after vaccination of healthy adults

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Amino acids in pneumolysin important for hemolytic activity identified by random mutagenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Expression, purification and preliminary X-ray crystallographic analysis of PsaA, a putative metal-transporter protein of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200535101

7 January 2021

Identifiers

DOI

10.1002/EJI.200535101

1 reference

25 December 2017

1 reference

25 December 2017